Huang P - Search Results

1

Novel biomarkers of nasopharyngeal carcinoma metastasis risk identified by reverse phase protein array based tumor profiling with consideration of plasma Epstein-Barr virus DNA load.

Xu T, Su B, Huang P, Wei W, Deng Y, Sehgal V, Wang D, Jiang J, Zhang G, Li A, Yang H, Claret FX. Xu T, et al. Among authors: huang p. Proteomics Clin Appl. 2017 May;11(5-6). doi: 10.1002/prca.201600090. Epub 2016 Dec 29. Proteomics Clin Appl. 2017. PMID: 27883284

2

Open-label, single-arm phase II study of pemetrexed in the treatment of patients with recurrent or metastatic nasopharyngeal carcinoma who have had prior platinum-based chemotherapy.

Zhang Y, Zhao L, Huang P, Wu J, Wang F, Huang Y, Zhang L. Zhang Y, et al. Among authors: huang p, huang y. Cancer Chemother Pharmacol. 2012 Oct;70(4):611-5. doi: 10.1007/s00280-012-1950-7. Epub 2012 Aug 19. Cancer Chemother Pharmacol. 2012. PMID: 22903536 Clinical Trial.

3

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy.

Fang W, Zhang J, Hong S, Zhan J, Chen N, Qin T, Tang Y, Zhang Y, Kang S, Zhou T, Wu X, Liang W, Hu Z, Ma Y, Zhao Y, Tian Y, Yang Y, Xue C, Yan Y, Hou X, Huang P, Huang Y, Zhao H, Zhang L. Fang W, et al. Among authors: huang p, huang y. Oncotarget. 2014 Dec 15;5(23):12189-202. doi: 10.18632/oncotarget.2608. Oncotarget. 2014. PMID: 25361008 Free PMC article.

4

Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma.

Zhang J, Fang W, Qin T, Yang Y, Hong S, Liang W, Ma Y, Zhao H, Huang Y, Xue C, Huang P, Hu Z, Zhao Y, Zhang L. Zhang J, et al. Among authors: huang p, huang y. Med Oncol. 2015 Mar;32(3):86. doi: 10.1007/s12032-015-0501-6. Epub 2015 Feb 22. Med Oncol. 2015. PMID: 25702326

5

Osteopontin is a useful predictor of bone metastasis and survival in patients with locally advanced nasopharyngeal carcinoma.

Hou X, Wu X, Huang P, Zhan J, Zhou T, Ma Y, Qin T, Luo R, Feng Y, Xu Y, Chen L, Zhang L. Hou X, et al. Among authors: huang p. Int J Cancer. 2015 Oct 1;137(7):1672-8. doi: 10.1002/ijc.29540. Epub 2015 Apr 29. Int J Cancer. 2015. PMID: 25824984

6

Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing.

Hu L, Lin Z, Wu Y, Dong J, Zhao B, Cheng Y, Huang P, Xu L, Xia T, Xiong D, Wang H, Li M, Guo L, Kieff E, Zeng Y, Zhong Q, Zeng M. Hu L, et al. Among authors: huang p. Front Med. 2016 Mar;10(1):61-75. doi: 10.1007/s11684-016-0436-0. Epub 2016 Mar 11. Front Med. 2016. PMID: 26969667

7

Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways.

Liu L, Huang P, Wang Z, Chen N, Tang C, Lin Z, Peng P. Liu L, et al. Among authors: huang p. BMC Cancer. 2016 Oct 19;16(1):813. doi: 10.1186/s12885-016-2853-5. BMC Cancer. 2016. PMID: 27756261 Free PMC article.

8

Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.

Liang W, Shen G, Zhang Y, Chen G, Wu X, Li Y, Li A, Kang S, Yuan X, Hou X, Huang P, Huang Y, Zhao H, Tian Y, Zhao C, Zhang L. Liang W, et al. Among authors: huang p, huang y. Chin J Cancer. 2016 Nov 25;35(1):98. doi: 10.1186/s40880-016-0160-9. Chin J Cancer. 2016. PMID: 27887636 Free PMC article.

9

Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignancies.

Li C, Jing B, Ke L, Li B, Xia W, He C, Qian C, Zhao C, Mai H, Chen M, Cao K, Mo H, Guo L, Chen Q, Tang L, Qiu W, Yu Y, Liang H, Huang X, Liu G, Li W, Wang L, Sun R, Zou X, Guo S, Huang P, Luo D, Qiu F, Wu Y, Hua Y, Liu K, Lv S, Miao J, Xiang Y, Sun Y, Guo X, Lv X. Li C, et al. Among authors: huang p, huang x. Cancer Commun (Lond). 2018 Sep 25;38(1):59. doi: 10.1186/s40880-018-0325-9. Cancer Commun (Lond). 2018. PMID: 30253801 Free PMC article.

10

Toripalimab plus intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma: an open-label single-arm, phase II trial.

Hua Y, You R, Wang Z, Huang P, Lin M, Ouyang Y, Xie Y, Zou X, Liu Y, Duan C, Liu Y, Gu C, Liu R, Yang Q, Jiang R, Zhang M, Ding X, Chen S, Lin C, Sun R, Chen M. Hua Y, et al. Among authors: huang p. J Immunother Cancer. 2021 Nov;9(11):e003290. doi: 10.1136/jitc-2021-003290. J Immunother Cancer. 2021. PMID: 34782428 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,893 results

Search Page

Filters